Bank Of America Corp Point Biopharma Global Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$6.86 - $10.86 $1.59 Million - $2.52 Million	-231,646 Reduced 59.51%	157,618 $1.43 Million
Q1 2023 May 12, 2023	SELL	$6.78 - $8.1 $179,758 - $214,755	-26,513 Reduced 6.38%	389,264 $2.83 Million
Q4 2022 Feb 10, 2023	BUY	$5.72 - $9.78 $1.35 Million - $2.3 Million	235,415 Added 130.52%	415,777 $3.03 Million
Q3 2022 Nov 14, 2022	BUY	$7.24 - $10.31 $662,669 - $943,663	91,529 Added 103.03%	180,362 $1.39 Million
Q2 2022 Aug 12, 2022	SELL	$5.6 - $9.5 $127,819 - $216,837	-22,825 Reduced 20.44%	88,833 $604,000
Q1 2022 May 16, 2022	BUY	$5.46 - $8.13 $179,950 - $267,948	32,958 Added 41.88%	111,658 $889,000
Q4 2021 Feb 08, 2022	BUY	$4.83 - $9.75 $353,000 - $712,578	73,085 Added 1301.6%	78,700 $441,000
Q3 2021 Nov 15, 2021	BUY	$7.42 - $11.26 $41,663 - $63,224	5,615 New	5,615 $43,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.